Skip to main content

Animations

MJFF Publications

4231 - 4240 of 6324 Results
Title
Year
  • Year
  • 2011
  • 2021
  • 2023
  • 2025
  • 2023
  • 2025
  • 2019
  • 2019
  • 2021
  • 2019
  • Summary Details
    OPEN
    Title: Lrrk2 p.Q1111H substitution and Parkinson’s disease in Latin America
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.003
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease
    Journal Name: Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/brb3.2086
    Citation Count: 6
  • Summary Details
    OPEN
    Title: A beginner’s guide into curated analyses of open access datasets for biomarker discovery in neurodegeneration
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-023-02338-1
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Identification of small molecule dimethyoxyphenyl piperazine inhibitors of alpha-synuclein fibril growth
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41598-025-17658-y
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?
    Journal Name: Environment International
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.envint.2023.107852
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine model
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-025-02859-6
    Citation Count: 1
  • Summary Details
    OPEN
    Title: 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-019-0470-7
    Citation Count: 149
  • Summary Details
    OPEN
    Title: MR‐based age‐related effects on the striatum, globus pallidus, and thalamus in healthy individuals across the adult lifespan
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/hbm.24771
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.010
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.038
    Citation Count: 21
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.